These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 30629029
1. Menin Upregulates FOXO1 Protein Stability by Repressing Skp2-Mediated Degradation in β Cells. Jiang Z, Xing B, Feng Z, Ma J, Ma X, Hua X. Pancreas; 2019 Feb; 48(2):267-274. PubMed ID: 30629029 [Abstract] [Full Text] [Related]
2. Menin and PRMT5 suppress GLP1 receptor transcript and PKA-mediated phosphorylation of FOXO1 and CREB. Muhammad AB, Xing B, Liu C, Naji A, Ma X, Simmons RA, Hua X. Am J Physiol Endocrinol Metab; 2017 Aug 01; 313(2):E148-E166. PubMed ID: 28270438 [Abstract] [Full Text] [Related]
3. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM, Tindall DJ. Proc Natl Acad Sci U S A; 2005 Feb 01; 102(5):1649-54. PubMed ID: 15668399 [Abstract] [Full Text] [Related]
4. Human Proislet Peptide Promotes Pancreatic Progenitor Cells to Ameliorate Diabetes Through FOXO1/Menin-Mediated Epigenetic Regulation. Jiang Z, Shi D, Tu Y, Tian J, Zhang W, Xing B, Wang J, Liu S, Lou J, Gustafsson JÅ, Hua X, Ma X. Diabetes; 2018 Jul 01; 67(7):1345-1355. PubMed ID: 29716892 [Abstract] [Full Text] [Related]
6. Regulation of forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: different mechanisms of induction of beta cell death in vitro. Kaiser G, Gerst F, Michael D, Berchtold S, Friedrich B, Strutz-Seebohm N, Lang F, Häring HU, Ullrich S. Diabetologia; 2013 Jul 01; 56(7):1587-95. PubMed ID: 23435785 [Abstract] [Full Text] [Related]
7. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer. Chae YC, Kim JY, Park JW, Kim KB, Oh H, Lee KH, Seo SB. Nucleic Acids Res; 2019 Feb 28; 47(4):1692-1705. PubMed ID: 30535125 [Abstract] [Full Text] [Related]
8. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, Simile MM, Bonelli P, Muroni MR, Seddaiu MA, Lim DS, Feo F, Pascale RM. Gastroenterology; 2009 Nov 28; 137(5):1816-26.e1-10. PubMed ID: 19686743 [Abstract] [Full Text] [Related]
9. Pancreatic-β-cell survival and proliferation are promoted by protein kinase G type Iα and downstream regulation of AKT/FOXO1. Wong JC, Vo V, Gorjala P, Fiscus RR. Diab Vasc Dis Res; 2017 Sep 28; 14(5):434-449. PubMed ID: 28631500 [Abstract] [Full Text] [Related]
10. FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation. Tomiyasu H, Habara M, Hanaki S, Sato Y, Miki Y, Shimada M. J Biol Chem; 2024 Apr 28; 300(4):107209. PubMed ID: 38519029 [Abstract] [Full Text] [Related]
11. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway. Zhang N, Qiu J, Zheng T, Zhang X, Hua K, Zhang Y. Oncol Rep; 2018 Mar 28; 39(3):1034-1042. PubMed ID: 29286125 [Abstract] [Full Text] [Related]
12. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Huang H, Tindall DJ. Biochim Biophys Acta; 2011 Nov 28; 1813(11):1961-4. PubMed ID: 21238503 [Abstract] [Full Text] [Related]
13. The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells. Fang D, Huang Z, Guan H, Liu J, Yao B, Xiao H, Li Y. Mol Med Rep; 2012 Jan 28; 5(1):233-8. PubMed ID: 21964769 [Abstract] [Full Text] [Related]
14. AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins. Saline M, Badertscher L, Wolter M, Lau R, Gunnarsson A, Jacso T, Norris T, Ottmann C, Snijder A. J Biol Chem; 2019 Aug 30; 294(35):13106-13116. PubMed ID: 31308176 [Abstract] [Full Text] [Related]
15. The regulation of FOXO1 and its role in disease progression. Xing YQ, Li A, Yang Y, Li XX, Zhang LN, Guo HC. Life Sci; 2018 Jan 15; 193():124-131. PubMed ID: 29158051 [Abstract] [Full Text] [Related]
16. Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription. Katona BW, Glynn RA, Paulosky KE, Feng Z, Davis CI, Ma J, Berry CT, Szigety KM, Matkar S, Liu Y, Wang H, Wu Y, He X, Freedman BD, Brady DC, Hua X. Cancer Res; 2019 May 01; 79(9):2195-2207. PubMed ID: 30877106 [Abstract] [Full Text] [Related]
17. Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction. Meng Z, Lv J, Luo Y, Lin Y, Zhu Y, Nie J, Yang T, Sun Y, Han X. Endocrinology; 2009 Dec 01; 150(12):5284-93. PubMed ID: 19837872 [Abstract] [Full Text] [Related]
18. Inhibition of FOXO1/3 promotes vascular calcification. Deng L, Huang L, Sun Y, Heath JM, Wu H, Chen Y. Arterioscler Thromb Vasc Biol; 2015 Jan 01; 35(1):175-83. PubMed ID: 25378413 [Abstract] [Full Text] [Related]
19. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding. Jang H, Lee GY, Selby CP, Lee G, Jeon YG, Lee JH, Cheng KK, Titchenell P, Birnbaum MJ, Xu A, Sancar A, Kim JB. Nat Commun; 2016 Jul 14; 7():12180. PubMed ID: 27412556 [Abstract] [Full Text] [Related]
20. Leucine promotes differentiation of porcine myoblasts through the protein kinase B (Akt)/Forkhead box O1 signalling pathway. Zhang S, Chen X, Huang Z, Chen D, Yu B, Chen H, Luo J, He J, Zheng P, Yu J. Br J Nutr; 2018 Apr 14; 119(7):727-733. PubMed ID: 29569540 [Abstract] [Full Text] [Related] Page: [Next] [New Search]